These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Volatile Organic Compounds in the Early Diagnosis of Non-healing Surgical Wounds: A Systematic Review. Reeves N; Phillips S; Hughes A; Maddocks S; Bates M; Torkington J; Robins L; Cornish J World J Surg; 2022 Jul; 46(7):1669-1677. PubMed ID: 35397678 [TBL] [Abstract][Full Text] [Related]
67. Rational Design of Peptides Derived from Odorant-Binding Proteins for SARS-CoV-2-Related Volatile Organic Compounds Recognition. Wang J; Sakai K; Kiwa T Molecules; 2022 Jun; 27(12):. PubMed ID: 35745038 [TBL] [Abstract][Full Text] [Related]
68. Proteomic Signatures of Antimicrobial Resistance in Deatherage Kaiser BL; Birdsell DN; Hutchison JR; Thelaus J; Jenson SC; Andrianaivoarimanana V; Byström M; Myrtennäs K; McDonough RF; Nottingham RD; Sahl JW; Schweizer HP; Rajerison M; Forsman M; Wunschel DS; Wagner DM Front Med (Lausanne); 2022; 9():821071. PubMed ID: 35223919 [TBL] [Abstract][Full Text] [Related]
69. Recent Advancements and Novel Approaches Contributing to the Present Arsenal of Prophylaxis and Treatment Strategies Against Category A Bacterial Biothreat Agents. Patnaik A; Rai SK; Dhaked RK Indian J Microbiol; 2023 Jun; 63(2):161-172. PubMed ID: 37325016 [TBL] [Abstract][Full Text] [Related]
70. Soil volatilomics uncovers tight linkage between soybean presence and soil omics profiles in agricultural fields. Kuchikata H; Sano M; Fujiwara F; Murashima K; Kumaishi K; Narukawa M; Nose Y; Kobayashi M; Hamamoto S; Kobayashi NI; Sugiyama A; Nihei N; Ichihashi Y; Kusano M Sci Rep; 2024 Sep; 14(1):20541. PubMed ID: 39232061 [TBL] [Abstract][Full Text] [Related]
71. Receptor mimicry as novel therapeutic treatment for biothreat agents. Thomas RJ Bioeng Bugs; 2010; 1(1):17-30. PubMed ID: 21327124 [TBL] [Abstract][Full Text] [Related]
72. Values for victims and vectors of disease. Kugelberg E J Med Ethics; 2022 Sep; 48(9):641-642. PubMed ID: 34321353 [TBL] [Abstract][Full Text] [Related]
73. Scent dog identification of samples from COVID-19 patients - a pilot study. Jendrny P; Schulz C; Twele F; Meller S; von Köckritz-Blickwede M; Osterhaus ADME; Ebbers J; Pilchová V; Pink I; Welte T; Manns MP; Fathi A; Ernst C; Addo MM; Schalke E; Volk HA BMC Infect Dis; 2020 Jul; 20(1):536. PubMed ID: 32703188 [TBL] [Abstract][Full Text] [Related]
74. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism. Blasco H; Bessy C; Plantier L; Lefevre A; Piver E; Bernard L; Marlet J; Stefic K; Benz-de Bretagne I; Cannet P; Lumbu H; Morel T; Boulard P; Andres CR; Vourc'h P; Hérault O; Guillon A; Emond P Sci Rep; 2020 Oct; 10(1):16824. PubMed ID: 33033346 [TBL] [Abstract][Full Text] [Related]
75. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives. Mahmud I; Garrett TJ J Am Soc Mass Spectrom; 2020 Oct; 31(10):2013-2024. PubMed ID: 32880453 [TBL] [Abstract][Full Text] [Related]
76. SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum. Bruzzone C; Bizkarguenaga M; Gil-Redondo R; Diercks T; Arana E; García de Vicuña A; Seco M; Bosch A; Palazón A; San Juan I; Laín A; Gil-Martínez J; Bernardo-Seisdedos G; Fernández-Ramos D; Lopitz-Otsoa F; Embade N; Lu S; Mato JM; Millet O iScience; 2020 Oct; 23(10):101645. PubMed ID: 33043283 [TBL] [Abstract][Full Text] [Related]